MLchartDataset catalogue

monocarboxylate transporter 1 inhibitor AZD3965

Term · Oncology and biomedicine · MLC-T-ONC-015241

An orally available inhibitor of monocarboxylate transporter 1 (MCT1), with potential antineoplastic activity. Upon oral administration, MCT1 inhibitor AZD3965 binds to MCT1 and prevents the transport of lactate into and out of the cell. This leads to an accumulation of lactate, intracellular acidification, and eventually cancer cell death. MCT1, a protein overexpressed on tumor cells, is responsible for the transport of monocarboxylates across the cell membrane and plays a key role in cell metabolism.

Table 1. Record
IdentifierMLC-T-ONC-015241
FieldOncology and biomedicine
SynonymsMCT1 inhibitor AZD3965
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015241",
  "term": "monocarboxylate transporter 1 inhibitor AZD3965",
  "field": "Oncology and biomedicine",
  "definition": "An orally available inhibitor of monocarboxylate transporter 1 (MCT1), with potential antineoplastic activity. Upon oral administration, MCT1 inhibitor AZD3965 binds to MCT1 and prevents the transport of lactate into and out of the cell. This leads to an accumulation of lactate, intracellular acidification, and eventually cancer cell death. MCT1, a protein overexpressed on tumor cells, is responsible for the transport of monocarboxylates across the cell membrane and plays a key role in cell metabolism.",
  "synonyms": [
    "MCT1 inhibitor AZD3965"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/monocarboxylate-transporter-1-inhibitor-azd3965/"
}

Record 11,218 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.